Sunshine Biopharma, Inc. (SBFM)Healthcare | Drug Manufacturers - Specialty & Generic | Fort Lauderdale, United States | NasdaqCM
1.15 USD
-0.12
(-9.449%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 1.14 -0.01 (-0.010%) ⇩ (Aug. 28, 2026, 7:31 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 3:19 a.m. EDT
The immediate outlook is severely clouded by massive dilution and a collapsing price structure. The stock recently executed a reverse split to maintain listing status, yet it immediately faced a $6 million equity raise that sent shares tumbling, followed by another public offering closing. This pattern of continuous capital raising suggests the company cannot fund operations without selling ownership stakes, which is destroying shareholder value. Technically, the price has detached from its 50-day and 200-day averages, trading at a fraction of book value due to the sheer magnitude of the decline rather than intrinsic worth. While analysts project a target price of $56, this figure appears disconnected from the reality of a company hemorrhaging cash with negative operating margins and no revenue growth. The statistical models also predict a further drop, though their low confidence makes them less relevant than the fundamental bleeding. There is no near-term catalyst to arrest this freefall. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.304981 |
| AutoARIMA | 0.308759 |
| AutoETS | 0.309908 |
| AutoTheta | 0.577305 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 33% |
| H-stat | 76.74 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.084 |
| Excess Kurtosis | -1.60 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 2.463 |
| Revenue per Share | 49.666 |
| Market Cap | 4,458,937 |
| Forward P/E | 0.01 |
| Beta | 1.31 |
| Profit Margins | -16.50% |
| Website | https://sunshinebiopharma.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.91180557 |
| Address1 | 333 Las Olas Way |
| Address2 | CU4 Suite 433 |
| All Time High | 197,400.0 |
| All Time Low | 1.01 |
| Ask | 1.48 |
| Ask Size | 2 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 1,183,330 |
| Average Daily Volume3 Month | 762,732 |
| Average Volume | 762,732 |
| Average Volume10Days | 1,183,330 |
| Beta | 1.31 |
| Bid | 0.9072 |
| Bid Size | 2 |
| Book Value | 43.832 |
| City | Fort Lauderdale |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.15 |
| Current Ratio | 5.457 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 1.28 |
| Day Low | 1.14 |
| Debt To Equity | 2.463 |
| Display Name | Sunshine Biopharma |
| Dividend Date | 1,586,131,200 |
| Earnings Timestamp End | 1,755,547,200 |
| Earnings Timestamp Start | 1,755,201,600 |
| Ebitda | -4,848,974 |
| Ebitda Margins | -0.13718 |
| Enterprise To Ebitda | 1.831 |
| Enterprise To Revenue | -0.251 |
| Enterprise Value | -8,879,505 |
| Eps Forward | 199.8 |
| Eps Trailing Twelve Months | -8.29 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.6282 |
| Fifty Day Average Change | -0.47820008 |
| Fifty Day Average Change Percent | -0.2936986 |
| Fifty Two Week Change Percent | -91.18056 |
| Fifty Two Week High | 24.3 |
| Fifty Two Week High Change | -23.15 |
| Fifty Two Week High Change Percent | -0.9526749 |
| Fifty Two Week Low | 1.01 |
| Fifty Two Week Low Change | 0.13999999 |
| Fifty Two Week Low Change Percent | 0.13861385 |
| Fifty Two Week Range | 1.01 - 24.3 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,644,935,400,000 |
| Float Shares | 3,808,824 |
| Forward Eps | 199.8 |
| Forward P E | 0.0057557556 |
| Free Cashflow | -2,011,131 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 50 |
| Fullday Change | -0.12 |
| Fullday Change Percent | -9.44882 |
| Fullday Price | 1.14 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.303 |
| Gross Profits | 10,710,057 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.01767 |
| Held Percent Institutions | 0.07132 |
| Implied Shares Outstanding | 3,877,337 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Ipo Expected Date | 2,022-02-15 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,780,272,000 |
| Last Split Factor | 1:10 |
| Long Business Summary | Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida. |
| Long Name | Sunshine Biopharma, Inc. |
| Market | us_market |
| Market Cap | 4,458,937 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_78729055 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -5,832,664 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 4,924,217 |
| Number Of Analyst Opinions | 1 |
| Open | 1.27 |
| Operating Cashflow | -5,352,750 |
| Operating Margins | -0.17411 |
| Payout Ratio | 0.0 |
| Phone | 954 330 0684 |
| Post Market Change | -0.00999999 |
| Post Market Change Percent | -0.8695644 |
| Post Market Price | 1.14 |
| Post Market Time | 1,787,959,873 |
| Previous Close | 1.27 |
| Price Hint | 4 |
| Price To Book | 0.026236538 |
| Price To Sales Trailing12 Months | 0.12614836 |
| Profit Margins | -0.16500999 |
| Quick Ratio | 3.215 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | -0.12 |
| Regular Market Change Percent | -9.44882 |
| Regular Market Day High | 1.28 |
| Regular Market Day Low | 1.14 |
| Regular Market Day Range | 1.14 - 1.28 |
| Regular Market Open | 1.27 |
| Regular Market Previous Close | 1.27 |
| Regular Market Price | 1.15 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 436,303 |
| Return On Assets | -0.09906 |
| Return On Equity | -0.21917999 |
| Revenue Growth | -0.016 |
| Revenue Per Share | 49.666 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 3,877,337 |
| Shares Percent Shares Out | 0.0191 |
| Shares Short | 73,942 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 62,455 |
| Short Name | Sunshine Biopharma Inc. |
| Short Percent Of Float | 0.0191 |
| Short Ratio | 0.1 |
| Source Interval | 15 |
| State | FL |
| Symbol | SBFM |
| Target High Price | 56.0 |
| Target Low Price | 56.0 |
| Target Mean Price | 56.0 |
| Target Median Price | 56.0 |
| Total Cash | 14,029,781 |
| Total Cash Per Share | 3.618 |
| Total Debt | 678,338 |
| Total Revenue | 35,346,772 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -8.29 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 8.47355 |
| Two Hundred Day Average Change | -7.3235497 |
| Two Hundred Day Average Change Percent | -0.86428356 |
| Type Disp | Equity |
| Volume | 436,303 |
| Website | https://sunshinebiopharma.com |
| Zip | 33,301 |